Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2023. 6 of 8 entries say "Materialised", first in FY2024-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 19,300, equivalent to 1.5% of the total 1,289,200 shares issued.」
While shares continue to be issued through the exercise of stock acquisition rights, the number of potential shares at the end of the fiscal year declined from 31,400, or 2.5%, in the previous fiscal year to 19,300, or 1.5%. - 2026-08-12MaterialisedEarnings
「Issuance of new shares (exercise of share acquisition rights)」
The statement of changes in shareholders' equity records the issuance of new shares through the exercise of share acquisition rights during the fiscal year, increasing capital and the capital reserve by ¥3,321 thousand; the number of shares outstanding at year-end was 1,289,200. - FY2026-H1MaterialisedAnnual report
「1 July 2025–31 December 2025 Increase in total shares issued 3,000 shares Balance of total shares issued 1,280,300 shares Increase due to the exercise of share options.」
During the interim accounting period, 3,000 shares were issued through the exercise of share options, increasing total shares issued from 1,277,300 to 1,280,300. Part of the dilution risk has continued to materialize as actual share issuances. - FY2025MaterialisedAnnual report
「1 July 2024–30 June 2025 (Note) 5 7,200 1,277,300 2,178 58,914 2,178 8,914」
During the fiscal year, 7,200 shares were issued through the exercise of share options, increasing total shares issued from 1,270,100 to 1,277,300. Meanwhile, potential shares outstanding at the fiscal year-end declined to 31,400, or 2.5% of total shares issued. - FY2024MaterialisedAnnual report
「1 July 2023–30 June 2024 (Note) 5 25,100 1,270,100 6,735 56,735 6,735 6,735 (Note) 5. Increase due to the exercise of share options (stock options).」
During the fiscal year, 25,100 shares were issued through the exercise of share options, increasing total shares issued from 1,245,000 to 1,270,100. Part of the potential dilution has materialized as an actual share issuance. - FY2024-Q3MaterialisedAnnual report
「1 January 2024–31 March 2024 (Note) 2,300 1,255,700 627 52,857 627 2,857 (Note) Increase due to the exercise of share options (stock options).」
During the third quarter, 2,300 shares were issued through the exercise of share options, bringing total shares issued to 1,255,700. A further portion of the potential dilution has materialized as an actual share issuance. - FY2024-Q2MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 2 8,400 1,253,400 2,229 52,229 2,229 2,229 (Note) 1. Based on resolutions adopted at the ordinary general meeting of shareholders held on 27 September 2023, the company reduced stated capital by ¥185,400 thousand (reduction ratio: 78.7%) and capital reserves by ¥225,400 thousand (reduction ratio: 100.0%) and transferred the amounts to other capital surplus, as part of its financial strategy to achieve agile and flexible capital management and maximize shareholder returns with a view to increasing corporate value over the medium to long term. 2. Increase due to the exercise of share options (stock options).」
During the quarter, 8,400 shares were issued through the exercise of share options, increasing total shares issued from 1,245,000 to 1,253,400. Part of the previously disclosed dilution risk has materialized as an actual share issuance. The amount is quantified. - FY2023First statedAnnual report
「As of the date of submission of this document, the potential shares represented by these share options totaled 64,200 shares, equivalent to 5.16% of the total 1,245,000 shares issued.」
The company discloses potential dilution from the exercise of share options granted to officers and employees as 64,200 shares, equivalent to 5.16% of total shares issued.